fda glp-1 enforcement news warns Novo Nordisk of unreported side effects Compound versions of GLP-1 drugs
Description
10.3389/fcimb.2025.1508893 Front Cell Infect Microbiol
Studies showed that retained gastric fooda common symptomhas only 32-67% positive predictive value depending on the patient population
Even a modest 5% reduction in body weight can lead to measurable improvements in your blood sugar, cholesterol, blood pressure and overall metabolic health
Coverage often limits to patients with a BMI of 30 or higher (or 27+ with weight-related comorbidities)
To view a copy of this licence, visit About this article Cite this article Puszkarska, A.M., Taddese, B., Revell, J
A meta-analysis also reported diagnoses of medullary thyroid carcinoma in patients taking GLP-1RAs, reinforcing the at-risk status as a contraindication to GLP-1RA treatment
